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Opioids are a class of drug normally associated with analgesia (reduced pain) (Chahl, 
L., 1996). In other words, when an opioid activates mu opioid receptors, it can result in an 
analgesic response. Unfortunately, it is also known to produce dependence in some patients. 
Dependence can also lead to unwanted side effects such as withdrawal. Treating dependence 
can be challenging because of the discomfort of withdrawal. This study evaluated if exercise 
such as running, can help decrease the severity of withdrawal, after the animals have 
developed a tolerance to the opioid. This project is trying to mediate the strength of 
withdrawal. Research has linked physical activity to improvements in cognition and overall 
brain function in the human body (Hillman, et al., Kramer, 2008). Non-human animal model 
allows access to causal mechanisms of whether exercise can reduce opioid tolerance in 
general. If exercise can reduce symptoms of withdrawal, it can inform clinical models and 
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 Opioids are among the most commonly abused drugs in the United States (Eisch, 
Barrot, Schad, Self, & Nestler, 2000). Opioid prescriptions have increased dramatically over 
the past 20 years and opioids such as oxycodone (Oxycontin), morphine and hydrocodone 
have become increasingly popular (Drewes, Jensen, Nielsen, Droney, Christrup, Arendt-
Nielsen, Riley & Dahan, 2012). In the United States, medical use of opioids increased 400% 
between 1996 and 2000 (Gallego, Baron, & Arranz, 2007). At present, 86% of the market 
consists of four opioids: controlled-release hydromorphone, controlled-release morphine, 
controlled-release oxycodone and transdermal fentanyl (Gallego, Baron, & Arranz, 2007). 
Opioids’ ability to produce profound delight and their ability to abolish pain has ignited the 
mind of humans for years (Mehendale, Goldman, Mehendale, Rana, 2013). Examining 
opioids and their use in the light of scientific knowledge, is clear that the history of opioid 
use is littered with the comparison of originality, anticipation, satisfaction, scientific progress 
and social disappointment (Mehendale, et al., 2013).  
When used properly, opioids have the capacity to relieve pain and discomfort, but 
when used improperly (opioid use that is not medically authorized), it can cause overdose, 
dependence or tolerance, addiction, and sometimes death (Mehendale, et al, 2013). These 
drugs act by binding to opioid receptors in the body and block the transmission of pain 
messages to the brain (Mehendale, et al., 2013). Used correctly, opioids are helpful for 
people suffering from chronic pain or pain from surgery.  
__________  




Unrelieved pain due to surgery, trauma, cancer or even noncancer related conditions, 
continues to be a major public health concern (Joranson, et al., 2000). Even though there are 
many nonpharmacologic medications such as acupuncture, therapy, relaxation techniques etc, 
that can be used for pain relief, opioids such as oxycodone, are the basis of pain management 
(Joranson, et al., 2000). Opioids can have a high abuse rate, making it regulated under 
international and national narcotics abuse and controlled substance laws (Joranson, et al., 
2000). These laws try to serve a dual purpose at allowing proper treatment and care for those 
suffering from pain or discomfort, all while preventing these substances from become 
misused and abused (Joranson, et al., 2000). Health care providers are reluctant to prescribe, 
administer or dispense opioids to patients, due to the possibility of addiction or misuse 
(Joranson et al., 2000).  
Dependence/Tolerance  
 Drug addiction/misuse can be described as a chronic, relapsing disorder characterized 
by compulsive drug seeking, all the while knowing the harmful consequences, and long-
lasting changes in the brain the drug can do (National Institute on Drug Abuse, 2018). 
Professionals try to avoid using the word addiction and instead use, tolerance, dependence or 
misuse (National Institute on Drug Abuse, 2018). The difference between addiction and 
tolerance is, tolerance is the need to take higher doses of a drug to get the same effect 
(National Institute on Drug Abuse, 2018). It often accompanies dependence, and it can be 
difficult to distinguish the two.  
Dependence can occur with the regular (daily or almost daily) use of any substance, 
legal or illegal, even when taken as prescribed (National Institute on Drug Abuse, 2018). It  
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occurs because the body naturally adapts to regular exposure to a substance (prescription 
drug) (National Institute on Drug Abuse, 2018). When that substance is taken away, 
symptoms can emerge while the body re-adjusts to the loss of the substance (National 
Institute on Drug Abuse, 2018). Physical dependence can lead to craving the drug to relieve 
the withdrawal symptoms (National Institute on Drug Abuse, 2018; Siegel, 2008). Opioids 
are increasingly being misused (Trivedi, Shaikh, & Gwinnut, 2007). This behavior of misuse 
can lead to addiction or possible overdose (Trivedi, Shaikh, et al., 2007). A defining 
characteristic of addiction is the appearance of drug withdrawal symptoms when drug use 
terminates (Siegel, Ramos, 2002). These symptoms may occur long after the last drug 
administration and may be one reason for relapse (Siegel, Ramos, 2002). A drug that 
mediates these symptoms would be a useful addiction treatment tool (Siegel, Ramos, 2002). 
Chronic drug administration may influence the addiction process of the body by 
developing a dependence to a certain drug, which can result in withdrawal behavior (Robbins 
& Everitt, 1999). It is important to understand how addiction works at the behavioral, 
cognitive and neuropsychological levels (Robbins & Everitt, 1999). Drug-seeking behavior 
can become powerfully associated with environmental cues, which, as conditioned stimuli, 
predict not only the availability of drugs and their associated hedonic (pleasant or unpleasant) 
effects, but also aversive withdrawal states (Robbins & Everitt, 1999). 
Many drugs that support compulsive self-administration will produce some type of 
dependence when the drug is withdrawn (Tiffany, 1990). Withdrawal symptoms include, 
anhedonia (inability to feel pleasure), negative affect, and craving (Bock, 1999). Opioid 
withdrawal symptoms often include restlessness, insomnia, vomiting, muscle and bone pain,  
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diarrhea and cold flashes (National Institute on Drug Abuse, 2007). Relief from these 
symptoms is believed to be a major factor that motivates drug use (Bock, 1999). Patients who 
have been prescribed an opioid for pain management and take the drug for two or more 
weeks, often report experiencing withdrawal symptoms when the drug is discontinued 
(Wakim, 2012). 
At the cellular level, opioids work by activating opioid receptors (Trivedi, Shaikh, et 
al., 2007). Naturally occurring opioid compounds are found in plants and produced in the 
body (endogenous opioids), where they are distributed throughout the central nervous system 
(CNS) (Trivedi, Shaikh, et al., 2007). These endogenous compounds are peptides that have 
variable potency and are preferentially bound by different opioid receptors; mu, kappa and 
delta receptors (Trivedi, Shaikh, et al., 2007). They have numerous actions including 
modulation of pain and control of the cardiovascular system, particularly in shock (Trivedi, 
Shaikh, et al., 2007). Although of interest to pharmacologists, endogenous opioids currently 
have no clinical role (Trivedi, Shaikh, et al., 2007). Synthetic and semi-synthetic opioids are 
widely used clinically, primarily for their analgesic actions (Trivedi, Shaikh, et al., 2007).  
When an opioid such as oxycodone or morphine binds to one of these receptors, this 
leads to a conformation change (Trivedi, Shaikh, et al., 2007). Effects of a conformational 
change regarding receptor sites, can be closing of calcium channels, stimulation of potassium 
efflux leading to hyperpolarization and reduced cyclic adenosine monophosphate production 
(Trivedi, Shaikh, et al., 2007). This means there is a reduction in neuronal cell excitability, 
that in turn results in reduced nociceptive (pain) impulses (Trivedi, Shaikh, et al., 2007).  
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Opioids such as oxycodone and morphine can cause initial feelings of pleasure by acting on 
the natural reward system in the brain (National Institute on Drug Abuse, 2007).  
Oxycodone 
Morphine has traditionally been the recommended choice of strong opioid for pain 
(Drewes, et al., 2012). In recent years, there has been growing availability of other alternative 
strong opioids, including, oxycodone, buprenorphine, hydromorphone, methadone, alfentanil 
and fentanyl (Drewes, et al., 2012). Previous behavioral studies looking at rats, compared 
oxycodone to morphine and found significantly weaker and briefer antinociception (reduced 
sensitivity to pain) in the tail flick and hot plate tests after intrathecal and 
intracerebroventricular administration (Kalso, 2005). Opioids are prescribed mainly to 
relieve pain symptoms, but they can have negative effects including drowsiness and physical 
dependence (Rapeli, et al., 2006). Over the past 10 years, there has been a resurgence of 
interest in the role of urges and cravings in physical dependence (Tiffany, 1990).  
Pharmaceutical companies introduced new formulations, such as extended release 
oxycodone (OxyContin), which were frequently prescribed because of a presumed lower 
likelihood of abuse, while in fact, were heavily abused (Jones, Viswanath, Peck, Kaye, Gill, 
& Simopoulos, 2018). Today oxycodone is mainly used as controlled-release tablets (drug is 
released slowly after ingestion) for chronic pain (Kalso, 2005). However, both morphine and 
oxycodone provide effective analgesia in acute and chronic pain (Kalso, 2005). Oxycodone 
has a more favorable pharmacokinetic profile (Kalso, 2005).  
Oxycodone’s oral (ingested) bioavailability (substance entered into the system to 
have an active effect) is significantly higher and therefore the individual variation in  
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bioavailability and expected plasma concentrations is less (Kalso, 2005). This variation 
means that the higher effect a compound has on an individual’s system, the more that drug is 
binding to its proper receptors, rather than free flowing throughout the body, creating lower 
plasma concentration (Kalso, 2005). Specifically, after oral administration, its bioavailability 
in humans is between 60 and 87% and its elimination half-life is 3–5 hours (Kummer, 
Hammann, Moser, Schaller, Drewe & Krahenbuhl, 2010; Gallego, Baron, & Arranz, 2007).  
Oxycodone has an analgesic potency similar to morphine and reveals affinity 
primarily for μ-opioid receptors (Kummer, et al., 2010). Clinical analgesia commences 
within one hour and in the controlled-release formulation, analgesia lasts for twelve hours 
(Gallego, et al., 2007). Oxycodone is heavily metabolized, with less than 10% of the orally 
administered drug expelled in urine (Kummer, et al., 2010). 
Both oxycodone and morphine cause typical opioid-related effects such as, the 
activation of the natural endogenous opioid system (Kalso, 2005). However, several reports 
indicate that oxycodone causes fewer hallucinations (Kalso, 2005). Less itching with 
oxycodone may be related to the fact that oxycodone leads to significantly less histamine 
being released than morphine (Kalso, 2005). Oxycodone penetrates easily into interstitial 
space and inside cells because of its relatively low molecular weight and its lipophilic nature 
(chemical compound being able to dissolve in fats, oils, lipids etc) (Gallego, et al., 2007). A 
high percentage of the drug remains outside the vascular compartments and is not eliminated 
by the kidneys or the liver, which contributes to its slow release (Gallego, et al., 2007). The 
antagonistic effects of oxycodone are those that are typically found in opioids (Gallego, et 
al., 2007).  
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Withdrawal 
According to the Diagnostic and Statistical Manual of Mental Disorders 
(DSM–5) criteria, signs and symptoms of opioid withdrawal include lacrimation (flow of 
tears) or rhinorrhea (nasal cavity is filled with a significant amount of mucus fluid), diarrhea, 
nausea/vomiting, pupillary dilation and photophobia (intolerance of light), insomnia, 
autonomic hyperactivity (tachypnea, hyperreflexia, tachycardia, sweating, hypertension, 
hyperthermia), and yawning (Shah, Huecker, 2019). Rate and intensity of these side effects 
tend to decrease in the course of time, as is the case for other opioids (Shah, Huecker, 2019).  
When opioid withdrawal signs are present, pharmacological management of opioid 
withdrawal is done by one of the following; gradual cessation of an opioid agonist 
(methadone), short-term use of a partial mu-opioid agonist (buprenorphine), or detoxification 
using opioid antagonists (naltrexone and naloxone) (Shah, Huecker, 2019). Naltrexone or 
more commonly known as Naloxone, is one of the most prescribed opioid antagonists for 
opioid abusers (Shah, Huecker, 2019). Naloxone dislodges an opioid from its binding site, 
causing a detox in the body (Chartoff, Carlezon, 2014). This detoxification process is a 
necessary step in treating opioid dependence (Chartoff, Carlezon, 2014). When the body goes 
through a detox from drugs such as opioids, it can be uncomfortable and very stressful 
(Chartoff, Carlezon, 2014). Abusers dependent on a substance, quickly learn the most 
effective way to stop the negative side effects of withdrawal, is to administer the drug again 
(Chartoff, Carlezon, 2014).  
Both acute drug administration and stress elicit states of arousal and engage many of 
the same neural circuits (Koob, 2008). Both activate the HPA axis, (hypothalamic-pituitary- 
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adrenal axis) which result in release of stress hormones and peptides (corticosterone, 
glucocorticoids, endogenous opioids) (Koob, 2008). Corticosterone can enhance dopamine 
release, which is one of the main pathways activated when drug of abuse is administered 
(Chartoff, Carlezon, 2014). Over time, when abusers have become dependent on a drug, the 
withdrawal results in activation of that HPA stress response, causing distress and discomfort 
(Chartoff, Carlezon, 2014). Understanding the neurobiology behind opioid withdrawal is a 
key factor to help clinicians develop a proper treatment plan for those seeking help (Chartoff, 
Carlezon, 2014). 
 Exercise/Benefits   
Physical activity, specifically exercise, has been suggested as a potential treatment for 
drug addiction/abuse and a method of mediating withdrawal symptoms (Bock 1999; Lynch, 
et al., 2013). Exercise and behavioral enrichment paradigms, such as environmental 
enrichment, rehabilitation training, and learning, affect different factors within the brain, 
including regulation of growth factors, neurogenesis, structural changes, brain derived 
neurotrophic factors and even protect against apoptosis (cell death) (Cotman & Berchtold, 
2002).  
Exercise has demonstrated substantial benefits in terms of mental and physical health 
with improvements in cardiovascular health and health-related quality of life, and reduction 
in the risks for various chronic diseases (type-2 diabetes, coronary heart disease, obesity) 
(Weinstock, Wadeson, VanHeest, 2012). Exercise also has well-established beneficial effects 
on reducing symptoms of anxiety, lowering the risk of major depression relapse, decreasing 
urges to drink alcohol, and lessening nicotine withdrawal and cannabis and cigarette cravings  
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(Weinstock, et al., 2012). Additionally, exercise has greater benefits as a means of coping 
and managing depression than other substance-free activities. (Weinstock, et al., 2012). The 
benefits of exercise are abundant for mental and physical health, which is why exercise is 
recommended as an alternative treatment over other health methods (Weinstock, et al., 2012). 
Given the benefits noted, exercise has also harbored attention to the mechanism of 
action it brings to patients struggling with substance abuse (Weinstock, et al., 2012). Possible 
mechanisms could be, increased socialization, emotional regulation, decreased anxiety, 
improving management to stress etc. (Weinstock, et al., 2012).  It has been noted, those that 
use substances to self-medicate or avoid negative stimuli, could be using a drug as an 
alternative to the emotion, stress, anxiety, depression etc, that they are facing (Weinstock, et 
al., 2012). Opioids impact the brains natural reward pathway by releasing powerful 
neurotransmitters, eliciting feelings of pleasure (Weinstock, et al., 2012). Since the human 
body, has a natural endogenous opioid system, research has shown, exercise can release those 
endogenous opioids in the central and peripheral nervous system, resulting in that sense of 
pleasure and reward that a compound would (Weinstock, et al., 2012). Dopamine is a natural 
neurotransmitter in the body that is released during pleasure/reward (Greenwood et al., 2011; 
MacRae et al., 1987). 
Expanding on the neurobiological process of what exercise does, aerobic exercise 
stimulates the release of endogenous opioid peptides and increases the nociceptive (pain) 
threshold in a naloxone-reversible manner (Greenwood et al., 2011; MacRae et al., 1987). 
Mechanistically, physical activity and exercise activate the same reward pathway. This is the 
same reward pathway as drugs of abuse (mesolimbic pathway), through increases in  
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dopamine concentrations and dopamine receptor binding (Greenwood et al., 2011; MacRae 
et al., 1987).  
Physical exercise can lead to activation of serotonin networks as well as 
dopaminergic networks (Greenwood et al., 2011; MacRae et al., 1987). As mentioned, when 
an opioid is administered in the body, not only does it block pain receptors, but it activates 
that dopamine/mesolimbic pathway, creating feelings of pleasure (Greenwood et al., 2011; 
MacRae et al., 1987). Endogenous opioids have chemical properties similar to that of opioids 
such as oxycodone and morphine, which potentially makes exercise a compatible substitute 
for drug abuse (Weinstock, et al., 2012; Lynch, et al., 2013).  
By the early 1990s, converging evidence suggested that many drugs of abuse act 
through mechanisms involving the brain neurotransmitter dopamine and different neural 
structures, including: the nucleus accumbens, ventral tegmental area, amygdala and 
prefrontal cortex (Robbins & Everitt, 1999). During exercise, sensitivity to the 
antinociceptive (blocking the detection of a painful stimulus) effects of mu opioids decreases, 
providing support that exercise may lead to the development of resistance to administered 
opioids (Smith & Lyle, 2006). Running has been shown to alter the levels of endogenous 
opioids in different regions of the rat brain (Boone, 1996; Werme, Thoren, Olson, & Brene, 
2000). Evidence for the role of the opioid system on the effects above is also derived from 
studies demonstrating that the opioid antagonist naloxone prevents elevation of the 




While opioid antagonists are an effective intervention for opioid dependence, there is 
room for improvement, as patients continue to abuse other substances (Weinstock, et al., 
2012). If exercise was introduced in a productive manner, considering all the risks, clinicians 
could have a possible treatment plan for opioid/drug abusers to slowly get their bodies, back 
to homeostasis (Weinstock, et al., 2012).  
Treatment Approaches  
 The path to drug abuse/addiction begins with the voluntary act of taking drugs. Over 
time, a person's ability to choose not to do so becomes compromised (National Institute on 
Drug Abuse, 2019). Seeking and taking the drug becomes compulsive (National Institute on 
Drug Abuse, 2019). This is mostly because of long-term drug exposure on brain function 
(National Institute on Drug Abuse, 2019). Addiction affects parts of the brain involved in 
reward and motivation, learning and memory, and control over behavior, such as low 
resistance to a drug, violence, personality changes etc. (National Institute on Drug Abuse, 
2019). People cannot simply stop using drugs for a few days and be cured. Most patients 
need long-term or repeated care to stop using completely or slowly get back to homeostasis 
and recover their lives (National Institute on Drug Abuse, 2019).  
 There are many options that have been successful in treating drug addiction, 
including, behavioral counseling, medication, medical devices and applications used to treat 
withdrawal symptoms (National Institute on Drug Abuse, 2019). Other options include 
evaluation and treatment for co-occurring mental health issues such as, depression and 
anxiety and long-term follow-up to prevent relapse (National Institute on Drug Abuse, 2019).  
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Medications help suppress withdrawal symptoms during detoxification (National Institute on 
Drug Abuse, 2019). Detoxification is not in itself treatment, but only the first step in the 
process (National Institute on Drug Abuse, 2019). Patients who do not receive any further 
treatment after detoxification usually resume their drug use (National Institute on Drug 
Abuse, 2019). 
 Acting on the same targets in the brain as oxycodone and morphine, methadone and 
buprenorphine suppress withdrawal symptoms and temporarily relieve cravings (National 
Institute on Drug Abuse, 2019). Naltrexone (Naloxone) blocks the effects of opioids at their 
receptor sites in the brain (National Institute on Drug Abuse, 2019). Some medications help 
patients reduce drug seeking and related behavior and help them become more open to 
behavioral treatments (National Institute on Drug Abuse, 2019). When determining treatment 
for those undergoing opioid abuse, it is vital to understand each individual patient (NIDA, 
2020). Men and woman can be different in determining treatment due to the different 
responsive behavior (NIDA, 2020).  
 Some research indicates that women are more sensitive to pain than men and more 
likely to have chronic pain, which could contribute to the high rates of opioid prescriptions 
among women of reproductive age (NIDA, 2020). In addition, women may be more likely to 
take prescription opioids without a prescription to cope with pain, even when men and 
women report similar pain levels (NIDA, 2020). Research also suggests that women are more 
likely to misuse prescription opioids to self-treat for other problems such as anxiety or 
tension (NIDA, 2020). However, from 1999 to 2016, deaths from prescription opioid  
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overdoses increased more rapidly for women (596 percent) than for men (312 percent) 
(NIDA, 2020). 
 Although agonist maintenance therapies produce better outcomes for most opioid 
addicts, they continue to seek opioid withdrawal primarily to lower the cost of their habit or 
as pretreatment before the therapeutic community or opioid antagonist maintenance (Kleber, 
2007). High relapse rates are probably less a meaning of withdrawal method and due more to 
reasons for seeking detoxification, post withdrawal treatment, or brain changes developed 
during dependence maintenance (Kleber, 2007). Due to previous research, treatment centers 
approach patients with many different options (Kleber, 2007). As mentioned, there are the 
agonist medications, therapy, counseling, rehabilitation etc. (Kleber, 2007). Withdrawal from 
opioids is uncomfortable and does cause various health problems (Kleber, 2007). Clinicians 
have seen treatment currently used in institutions as being effective for an acute amount of 
time (Kleber, 2007). One treatment that is not explored enough is the option of exercise as a 
treatment for withdrawal (Kleber, 2007). 
 Previously mentioned, exercise has shown many physiological and physical benefits 
on the body (Weinstock, et al., 2012). If there was a way to use exercise as a treatment for 
patients undergoing withdrawal, that should be further explored (Weinstock, et al., 2012). 
Exercise’s production of dopamine can help addicted individuals find other non-substance-
related hobbies to manage long-term recovery (Elevate Addiction Services, 2018). Some 
addiction recovery centers have even pushed for the implementation of opiate-recovery-
centric gymnasiums (Elevate Addiction Services, 2018). Easy exercise equipment access, 
they suspect, may promote the physical activity needed to combat acute and post-acute  
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withdrawal symptoms (Elevate Addiction Services, 2018). The act of practicing an exercise 
routine, and committing to a physical activity, can keep the mind off drug use, too (Elevate 
Addiction Services, 2018). Exercise during opiate withdrawal is surprisingly similar to 
traditional treatment methods (Elevate Addiction Services, 2018). Exercise is still being 
explored in depth and how to properly treat patients with exercise, if that is the diagnosis 
being prescribed (Weinstock, et al., 2012). Research has shown multiple benefits of exercise 
and if it can alleviate withdrawal symptoms in those struggling with addiction, there needs to 
be a harder push and more awareness for treatment centers to offer (Weinstock, et al., 2012).  
Purpose/Hypothesis  
 The purpose of this project is to evaluate whether exercise will mediate withdrawal 
symptoms in opioid-dependent female rats. The goal of which would be to potentially inform 













Animals and Housing 
Two cohorts of 20 mature Sprague Dawley female rats of 4 months (18 weeks, full 
growth) were ordered from Envigo and transported to the Jackson Street Laboratory. Female 
rats were chosen because female rats do not receive enough credit in biomedical research 
(Wizemann and Pardue, 2001). This is often on the assumption that results from males apply 
to females, or because of concern that hormonal cycles decrease the equality of study 
populations and confound effects of experimental manipulations (Wizemann and Pardue, 
2001).  
Rats were housed in a semi-self-contained housing system (Optirat©) two to each 
cage and given standard rodent chow and hard-wood chip (sani-chip) bedding. The rats were 
also given unrestricted access to food and water. The vivarium was maintained on a 
recommended 12-hour light/dark cycle (Miladi-Gorji, Rashidy-Pour, & Fathollahi, 2011). 
  Rats in the age range from around 28–42 days are often hyperactive and exhibit 
greater exploration in novel situations than other aged rats (Spear, 2000). They also 
frequently appear hyper-reactive to stimuli (high sensitivity), displaying substantially greater 
startle response amplitude than adults (Spear, 2000). Using rats 18 weeks of age, allow for a 
more reliable comparison with human primates undergoing drug abuse according to NIH. 
Young adults (age 18-25) are the biggest abusers of prescription opioid pain relievers 
(National Institute on Drug Abuse, 2015). Using rats aged around 4-6 months is the 
equivalent to 18-25 years of a human life span (Sengupta, 2012).  
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Treadmill Intervention  
In order to reduce stress and potential stress-related experimental confounds, all 
animals were given a period of five days to acclimate to their new surroundings  
prior to any experimental manipulation. During the acclimation period, all animals were 
handled daily and allowed to explore the treadmill apparatus that was used in the experiment 
once a day for three days prior to experimentation. Day 1—10 min at 10m/min, Day 2—15 
min at 12 m/min, Day 3—20 min at 15m/min (Burghardt, Fulk, Hand, & Wilsona, 2004). 
The LE8710RTS Five Lanes Touch Screen Treadmill (Panlab Harvard Apparatus) was used 
during this experiment. Panlab/Harvard Apparatus small animal treadmills are used for 
forced exercise training and provide accurate testing of fatigue in rodents.  
Procedures 
 This study consisted of four groups. Group one was exercise/saline group; this group 
received saline injections and exercise on specified day. Group two was no exercise/saline 
group; this group received just saline injections. Group 3 was exercise/oxycodone; this group 
received injections of oxycodone and exercise as well, on specified day. Group four was no 
exercise/oxycodone; this group received just oxycodone injections. The week of 
experimentation, the first cohort of rats (groups one and two) were removed from their home 
cages and injected with saline for 13 days at the same time of day. Rats were then placed 
back in their home cages. Tolerance for opioids can be produced rapidly in rats, typically 
within 2 weeks (Wakim, 2012).  
This study took place over 19 days per cohort. On day fourteen, group one walked on 
the treadmill for 1 hour at 15m/min. Withdrawal was assessed in both exercise and no  
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exercise groups by an injection of 1.0 mg/kg of naloxone on day 14 right after the treadmill 
exercise for group one. Group two was injected with 1.0mg/kg of naloxone after group one 
was complete. Withdrawal behaviors were then recorded. Naloxone is an opioid antagonist, 
which speeds up the process of withdrawal (Wheeler, Eliza, Jones, Stephen, Gilbert, Michael 
& Davidson, 2010).  
When the second cohort of rats arrived, they were allowed the same time of handling 
and treadmill acclimation as cohort one. During the week of experimentation for the second 
cohort, each rat in groups three and four were given opioid injections for 13 days. Due to 
manufacturing and time constraints, 10mg/kg of morphine had to be administered to groups 
three and four for two days, while the shipment of oxycodone arrived. The third day of 
injections, 10 mg/kg of oxycodone was then administered for the rest of the injection time 
frame. Day fourteen for the second cohort, group three walked on the treadmill for the same 
time, (1 hour at 15m/min) and group four remained in their home cages (Alaei, Borjeian, 
Azizi, Orian, Pourshanazari, & Hanninen, 2006). Naloxone was then administered to group 
three and four at 1.0mg/kg right after the treadmill task for group three. Group four received 
the same naloxone injection after group three was complete. Withdrawal behaviors were then 
recorded. 
Observer’s blind to the study analyzed withdrawal behavior for 30 min by observing 
a video that was taken of the rats during this period; Inter-rater reliability was calculated 
from the scores obtained by the raters (Miladi-Gorji, Rashidy-Pour, & Fathollahi, 2012; 
Kaka, Rahmanzade, Safee, & Haghparast, 2014; Azizi, Ranjbar-Slamloo, & Semnanian, 
2012; Liu, Rockhold, & Ho, 1999). Withdrawal signs were recorded and scored according to  
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a modified version of the Gellert–Holtzman scale (Miladi-Gorji, et al., 2012; Hammami-
Abrand Abadi, Miladi-Gorji, 2016): wet dog shakes (lateral and rotary motions of the head), 
(Richardson, McLemore, & Gauda, 2006), (1-2 shakes = 2; 3 or 4 shakes = 3; 4 or more 
shakes = 4), escape attempts, (leaping off the surface with all four paws), (Xiaohui, Cao, 
Guo, & Zhao, 2006), (2-4 attempts = 1, 5 to 9 attempts = 2, and 10 or more attempts = 3), 
abnormal posture/writhing, (the rat lies on the floor, while the belly is firmly pressing the 
surface; abdominal contractions are usually present), (Xiaohui, et al., 2006), teeth chattering, 
(the rat rapidly clicks teeth together), (Xiaohui, et al., 2006), and profuse salivation was 
scored for their presence and latency to first occurrence.  
A camera was set up in the lab to record withdrawal effects, allowing for the 
observers’ blind to the study to analyze the behavior. Immediately following testing for 
withdrawal, all rats were returned to standard cages and given unrestricted access to food  











The total sample size was 38 rats from both cohorts. There were ten rats per group, 
with two rats, one from group three and one from group four dying in week one and week 
two respectively. There were four groups overall, including exercise saline, no exercise 
saline, exercise oxycodone and no exercise oxycodone (see Table 1). 
Table 1 
Note: Each group for the study and what the group consists of. 
Interrater reliability was conducted with Cronbach’s alpha estimate of internal 
consistency, for scores from each rater for each withdrawal behavior (see Table 2).  
Table 2 
Note: The interrater reliability for the withdrawal behaviors from both raters.  
The results indicated the satisfactory level of internal consistency for the withdrawal 
behaviors between the raters. Due to teeth chatter, profuse salivation, and abnormal posture 
being on a latency time scale, and escape attempts and wet dog shakes being on a scoring 
scale, all variables were transformed into Z-scores to place everything on the same scale.  
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Z-scores from each withdrawal behavior were then combined in order to compute an 
overall withdrawal score for each animal. In order to test the hypothesis that exercise will 
potentially mediate withdrawal, a MANOVA was conducted between each withdrawal 
behavior to group. There was a significant difference for average teeth chatter between 
groups, F(3, 34)= 85.782, p<.001. Post hoc test using Bonferroni revealed statistical 
significance for teeth chatter between group (see Table 3) and (Figure 1).  
Table 3 
 Group Group Sig. 






























Note: The significant withdrawal behaviors between group of the MANOVA. 1 represents 
exercise/saline. 2 represents no exercise/saline. 3 represents exercise/oxycodone. 4 represents 









Figure 1. A chart showing the means and standard deviations of teeth chatter between each 
group. 
There was a significant difference for abnormal posture between groups, F(3, 34)= 
101.162, p<.001. Post hoc test using Bonferroni revealed statistical significance for abnormal 
posture between group (see Table 3) and (Figure 2). There was a significant difference for 
wet dog shakes, F(3, 34)= 10.477, p<.001 between groups.  
Figure 2 
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Post hoc test using Bonferroni revealed statistical significance for wet dog shakes between 
group (see Table 3) and (Figure 3).  
Figure 3 
 
Figure 3. A chart showing the means and standard deviations of wet dog shakes between 
each group.  
There was no significant difference for escape attempts (p>.05) between groups. Means and 
standard deviations for each significant withdrawal behavior between group can be seen in 
Table 4.  
Table 4 
 Group 1 Group 2 Group 3 Group 4 
Teeth Chatter M=.86 (SD=.08) M=.89 (SD=.00) M=-.96 (SD=.49) M=-.98 (SD=.49) 
Abnormal 
Posture 
M=-.26 (SD=.00) M=.88 (SD=.00) M=-.95 (SD=.56) M=-1.0 (SD=.37) 
Wet Dog 
Shakes 
M=-.63 (SD=.00) M=-.63 (SD=.00) M=.53 (SD=1.1) M=.88 (SD=1.0) 
Note: Means and standard deviations of the MANOVA for the significant withdrawal behaviors 
between group. Group 1 represents exercise/saline. Group 2 represents no exercise/saline. Group 3 
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Two-way ANOVA was conducted to compare the two independent variables (i.e. 
exercise and drug), to overall withdrawal. There was no significance difference between 
exercise conditions and overall withdrawal, F(1, 34)= .118, p= .733. There was however a 
significant difference between saline and oxycodone when examining overall withdrawal, 
F(1, 34)= 18.569, p<.001. Comparing exercise and no exercise within the saline condition, 
there was no significant difference, F(1, 34)= .001, p=.997. There was no significant 
difference when comparing exercise and no exercise within the oxycodone condition, F(1, 
34)= .199, p=.658. There was a significant difference when comparing saline and oxycodone 
between the exercise groups, F(1, 34)= 10.639, p=.003. There was also a significant 
difference when comparing saline and oxycodone between the no exercise groups, F(1, 34)= 
8.022, p=.008. Means and standard deviations for each significant withdrawal behavior 
between group can be seen in Table 5. 
Table 5 
 M SD 
Group 1 .22 .01 
Group 2 -.28 .55 
Group 3 .22 .00 
Group 4 -.21 .41 







The current study hypothesized that exercise would mediate withdrawals. The 
findings from the MANOVA showed significance for three of the withdrawal behaviors, 
which suggests that these specific behaviors have an impact on overall withdrawal. It is 
possible that certain withdrawal behaviors such as teeth chatter, abnormal posture and wet 
dog shakes, are more common behaviors seen in withdrawal and therefore had more data 
recorded. These behaviors might be more common because during drug withdrawal, the body 
will naturally give off these behaviors, while the drug is being detoxed from the body (Shah, 
Huecker, 2019). The Two-way ANOVA results show that exercise did not mediate 
withdrawals. However, there was a difference between saline and oxycodone, suggesting 
oxycodone impacted withdrawal which is to be expected.  
Exercise has many benefits on the brain and body that activate pathways the same 
way a drug does. In the future, exercise could be further explored at different time points 
over an extensive period of time. Another point to note, the administration of oxycodone 
could be given at intervals of two times a day to ensure dependence on that drug. This 
research still shows that rats were able to become dependent on oxycodone because they 
experienced withdrawal. Even though the differences between saline and oxycodone 
conditions were minimal, some possible explanations could be sample size and duration of 
time that could have impacted the study.  
 Exercise will always be a crucial part in maintaining overall body and brain health 
(Trivedi, et al., 2007). More research needs to be done on this topic of opioids because of its 
growing concern.  
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There are many treatment methods mentioned previously that have shown to be 
effective for patients. If there is a way to use natural methods to aid patients in getting back 
to their homeostasis, that research should be expanded. Future research can always improve 
this method as well as show support for exercise potentially mediating opioid withdrawals. 
Limitations  
 Limitations during this study were the sample size in each group. With an increase in 
sample size, there is always a possibility that it would provide more accurate mean values 
and greater power (Faber, Fonseca, 2014). The morphine administration for two days before 
oxycodone was used because the oxycodone had not come in yet. The administration of 
morphine was at the same dose and same volume calculation as was the oxycodone for the 
rest of the study. Morphine is very similar to oxycodone regarding the chemical properties of 
potency and affinity (Trivedi, et al., 2007). Even though they may have some percent 
differences, the choice to administer morphine first was the safer option to allow for the rats 
to ease into the transition of morphine to oxycodone  (Trivedi, et al., 2007). Each limitation 
was addressed properly and with the high concern of the safety for the animals and research 
assistants in the lab.  
Implications and Concluding Remarks 
This study extended the literature on the opioid epidemic as well as the complications 
with patients struggling with opioid withdrawal (Mehendale, et al., 2013; Joranson, et al., 
2000). There is extensive research regarding opioids and the major complications behind 
what they do (Mehendale, et al., 2013; Joranson, et al., 2000). The research is growing so 
that the public can understand how to treat or assess patients/people going through an opioid  
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abuse or addiction (National Institute on Drug Abuse, 2019). With the treatment centers 
doing what they can do to help ease the stress and irritability to their patients by providing 
medication, there is always more ways to address withdrawal (National Institute on Drug 
Abuse, 2019).  
This study focused on exercise as an adjunctive method to opioid antagonists 
(Greenwood et al., 2011; MacRae et al., 1987). Other research has supported that exercise 
has been shown to mediate withdrawal (Greenwood et al., 2011; MacRae et al., 1987). The 
research from these articles involve different extended time, methods, opioids and support for 
why exercise is a possible alternative (Greenwood et al., 2011; MacRae et al., 1987). Other 
research has reported that exercise does mediate withdrawal behaviors in opioid dependent 
rats (Alaei, et al., 2006; Hosseini, et al., 2009; Mokhtari-Zaer, et al., 2014; De La Garza, et 
al., 2016). The methods and procedures these researchers used, consisted of different exercise 
time frames, different opioids, and multiple time points/injection dosages compared to this 
current study (Alaei, et al., 2006; Hosseini, et al., 2009; Mokhtari-Zaer, et al., 2014; De La 
Garza, et al., 2016). Research has shown support for the opioid crisis that is rising in our 
society today (Joranson, et al., 2000). Prescriptions and insurance can also add to the 
negative consequences to those trying to get better/well (Joranson, et al., 2000). 
Research like the one conducted here, is trying to provide help and support for people 
in treatment facilities that have gone through extensive medication to get their heath back. 
Exercise has been shown is other literature to reduce the severity of withdrawal (Mokhtari-
Zaer, et al.,, 2014; Alaei, et al., 2006). The hope and goal from this study is to potentially 
educate researchers passionate about treatment, withdrawal, addiction, exercise and drug  
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compounds, that there is always an alternative. Other methods are constantly on the rise and 
maybe future precautions can be taken to put patients first and help find a successful 
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